Efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes in older patients: a systematic review and meta-analysis.

Back

ESC Professional Premium Access

Efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes in older patients: a systematic review and meta-analysis.

Session: Pharmacological therapy in heart failure (1)

Topic: Pharmacotherapy

Speaker: Doctor T. Fujisaki (Kumamoto, JP)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Tomohiro Fujisaki

Kumamoto University Hospital, Kumamoto (Japan)

0 follower

5 more presentations in this session

Torsemide versus furosemide in patients with heart failure: a systematic review and updated meta-analysis of randomised controlled trials

Speaker: Doctor L. Figueiredo Teixeira (Campina Grande, BR)

Modelling clinicians' decisions to adjust loop diuretic dose based on patient-reported symptoms to inform decision-aids in daily care of chronic heart failure

Speaker: Ms A. Bruninx (Maastricht, NL)

Comparison study of olmesartan and valsartan on myocardial metabolism in patients with dilated cardiomyopathy trial

Speaker: Professor K. Park (Busan, KR)

Differential response to interleukin-1 blockade with anakinra on cardiorespiratory fitness in patients with heart failure with preserved ejection fraction stratified according to ejection fraction

Speaker: Doctor M. Golino (Richmond, US)

Sex differences for the efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes: a systematic review and meta-analysis.

Speaker: Doctor T. Fujisaki (Kumamoto, JP)

Access the full session

Pharmacological therapy in heart failure (1)

Speakers: Doctor T. Fujisaki, Doctor L. Figueiredo Teixeira, Ms A. Bruninx, Professor K. Park, Doctor M. Golino...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes in older patients: a systematic review and meta-analysis.

About the speaker

Doctor Tomohiro Fujisaki

5 more presentations in this session

Torsemide versus furosemide in patients with heart failure: a systematic review and updated meta-analysis of randomised controlled trials

Modelling clinicians' decisions to adjust loop diuretic dose based on patient-reported symptoms to inform decision-aids in daily care of chronic heart failure

Comparison study of olmesartan and valsartan on myocardial metabolism in patients with dilated cardiomyopathy trial

Differential response to interleukin-1 blockade with anakinra on cardiorespiratory fitness in patients with heart failure with preserved ejection fraction stratified according to ejection fraction

Sex differences for the efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes: a systematic review and meta-analysis.

Access the full session

Pharmacological therapy in heart failure (1)

About the event

ESC Congress 2023

ESC 365 is supported by